Similar articles for PMID: 22609734

Year	Number of Results
1991	1
1993	2
1994	2
1996	2
1998	4
2000	4
2001	1
2002	3
2003	1
2004	2
2005	4
2006	4
2007	5
2008	2
2010	1
2011	5
2012	1
2013	2
2014	3
2016	2
2017	1
2018	1
2019	1
2024	0

1

Dale DC. Dale DC. Am J Clin Oncol. 2012 Jun;35(3):307. doi: 10.1097/COC.0b013e31823a53e7. Am J Clin Oncol. 2012. PMID: 22609734 No abstract available.

2

Different schedules of granulocyte growth factor support for patients with breast cancer receiving adjuvant dose-dense chemotherapy: a prospective nonrandomized study.

Hendler D, Rizel S, Yerushalmi R, Neiman V, Bonilla L, Braunstein R, Sulkes A, Stemmer SM. Hendler D, et al. Am J Clin Oncol. 2011 Dec;34(6):619-24. doi: 10.1097/COC.0b013e3181f94716. Am J Clin Oncol. 2011. PMID: 21217400

3

Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.

Koirala J, Gandotra SD, Rao S, Sangwan G, Mushtaq A, Htwe TH, Adamski A, Blessman D, Khardori NM. Koirala J, et al. J Viral Hepat. 2007 Nov;14(11):782-7. doi: 10.1111/j.1365-2893.2007.00870.x. J Viral Hepat. 2007. PMID: 17927614

4

Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.

Wong SF, Chan HO. Wong SF, et al. Pharmacotherapy. 2005 Mar;25(3):372-8. doi: 10.1592/phco.25.3.372.61608. Pharmacotherapy. 2005. PMID: 15843284

5

[Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].

Shi YK, Liu P, Yang S, Han XH, He XH, Ai B, Qin Y, Li B, Huang DZ, Zhang CG, Sun Y. Shi YK, et al. Ai Zheng. 2006 Apr;25(4):495-500. Ai Zheng. 2006. PMID: 16613688 Clinical Trial. Chinese.

6

Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.

Ikeda K, Tasaka T, Sasaki K, Murata M, Kitanaka A, Nagai M, Kawanishi K, Takahara J, Irino S. Ikeda K, et al. Leukemia. 1994 Nov;8(11):1838-41. Leukemia. 1994. PMID: 7526087

7

Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial.

Paul M, Ram R, Kugler E, Farbman L, Peck A, Leibovici L, Lahav M, Yeshurun M, Shpilberg O, Herscovici C, Wolach O, Itchaki G, Bar-Natan M, Vidal L, Gafter-Gvili A, Raanani P. Paul M, et al. Am J Hematol. 2014 Mar;89(3):243-8. doi: 10.1002/ajh.23622. Am J Hematol. 2014. PMID: 24178750 Free article. Clinical Trial.

8

Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.

Cho SG, Park YM, Moon H, Kim KM, Bae SS, Kim GB, Cho HS, Kim CC, Lee KS. Cho SG, et al. J Korean Med Sci. 1998 Dec;13(6):685-8. doi: 10.3346/jkms.1998.13.6.685. J Korean Med Sci. 1998. PMID: 9886182 Free PMC article.

9

Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.

Disis ML. Disis ML. Oncology (Williston Park). 2005 Apr;19(4 Suppl 2):5-9. Oncology (Williston Park). 2005. PMID: 15934493 Free article. Review. No abstract available.

10

Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.

Ghalaut PS, Sen R, Dixit G. Ghalaut PS, et al. J Assoc Physicians India. 2008 Dec;56:942-4. J Assoc Physicians India. 2008. PMID: 19322972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year